Psychiatry and Neurology, Epilepsy · San Antonio, TX
NPI
1548277866
Since 2006
Specialty
Psychiatry and Neurology, Epilepsy
Code 2084E0001X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
8300 Floyd Curl Dr
San Antonio, TX, 78229
Phone (210) 450-9700
Groups this clinician bills Medicare through
Medicare paid, 2024
$17K
216 services
Medicare patients, 2024
111
Average age 64
Drug cost, 2024
$1.5M
2,352 prescriptions
Company payments, 2025
$262
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Charles A Szabo was code 95816 (neurologic), 48 times for 45 patients. In total Charles A Szabo billed 216 services in 15 codes, and Medicare paid $17K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-10-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95816 Neurologic | Facility | 48 | 45 | $45.13 | $2,166 |
| 95720 Neurologic | Facility | 37 | 18 | $167.55 | $6,199 |
| 99214 Office E&M - Established | Office | 35 | 30 | $88.17 | $3,086 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 25 | 25 | $12.93 | $323 |
| 95819 Neurologic | Facility | 11 | 11 | $41.84 | $460 |
By year: 2022 $23K for 273 services; 2023 $16K for 182 services; 2024 $17K for 216 services.
Medicare prescription drug claims, 2024
In 2024, the drug Charles A Szabo prescribed most often to Medicare patients was Lacosamide, with 231 prescriptions and refills. In total Charles A Szabo wrote 2,352 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lacosamide Generic | 231 | 347 | 43 | $49K |
| Lamotrigine Generic | 197 | 364 | 45 | $5,700 |
| Clobazam Generic | 185 | 232 | 38 | $26K |
| Clonazepam Generic | 159 | 175 | 34 | $2,149 |
| Xcopri Cenobamate | 137 | 139 | 19 | $201K |
| Levetiracetam Generic | 136 | 265 | 34 | $5,450 |
| Briviact Brivaracetam | 123 | 125 | 19 | $227K |
| Zonisamide Generic | 97 | 193 | 21 | $5,992 |
| Lorazepam Generic | 71 | 74 | 17 | $300 |
| Epidiolex Cannabidiol (Cbd) | 62 | 62 | Under 11 | $331K |
| Felbamate Generic | 54 | 88 | Under 11 | $11K |
| Vimpat Lacosamide | 53 | 65 | 12 | $79K |
| Duloxetine Hcl Generic | 46 | 56 | Under 11 | $1,017 |
| Phenobarbital Generic | 45 | 51 | Under 11 | $761 |
| Rufinamide Generic | 40 | 40 | Under 11 | $35K |
Brand drugs: 634 claims; generic drugs: 1,673 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Charles A Szabo $262 ($262 in general payments such as food, travel and fees) from 5 companies. The largest payer was UCB, Inc. with $136.
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. UCB.BR | 1 | $136 |
| Otter Pharmaceuticals, LLC | 2 | $68.4 |
| Neurelis, Inc. | 1 | $32.44 |
| SK Life Science, Inc. | 1 | $16.13 |
| Aucta Pharmaceuticals, Inc. | 1 | $9.23 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.